0000932471-13-000410.txt : 20130130 0000932471-13-000410.hdr.sgml : 20130130 20130130080108 ACCESSION NUMBER: 0000932471-13-000410 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130130 DATE AS OF CHANGE: 20130130 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN IDEC INC. CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-42028 FILM NUMBER: 13557151 BUSINESS ADDRESS: STREET 1: 133 BOSTON POST ROAD CITY: WESTON STATE: MA ZIP: 02493 BUSINESS PHONE: 7814642000 MAIL ADDRESS: STREET 1: 133 BOSTON POST ROAD CITY: WESTON STATE: MA ZIP: 02493 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: VANGUARD CHESTER FUNDS CENTRAL INDEX KEY: 0000752177 IRS NUMBER: 232311358 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: PO BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482 BUSINESS PHONE: 6106691000 MAIL ADDRESS: STREET 1: P.O. BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482 FORMER COMPANY: FORMER CONFORMED NAME: VANGUARD PRIMECAP FUND/ DATE OF NAME CHANGE: 20011121 FORMER COMPANY: FORMER CONFORMED NAME: VANGUARD/PRIMECAP FUND INC DATE OF NAME CHANGE: 19940608 FORMER COMPANY: FORMER CONFORMED NAME: PRIMECAP FUND INC DATE OF NAME CHANGE: 19920703 SC 13G 1 biogenidecinc.htm biogenidecinc.htm - Generated by SEC Publisher for SEC Filing

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Schedule 13G

 

Under the Securities Exchange Act of 1934

(Amendment No.:0)*

 

 

 

Name of issuer:  Biogen Idec Inc

 

 

Title of Class of Securities:  Common Stock

 

 

CUSIP Number:  09062X103

 

 

Date of Event Which Requires Filing of this Statement: December 31, 2012

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

  (X) Rule 13d-1(b)

  (  ) Rule 13d-1(c)

  (  ) Rule 13d-1(d)

 

  *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

  The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

(Continued on the following page(s))

 

 

 

 

13G

CUSIP No.:  09062X103

 

 

1.  NAME OF REPORTING PERSON

  S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 

  VANGUARD CHESTER FUNDS - VANGUARD PRIMECAP FUND - 23-2311358

 

2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

 

A.

B. X 

 

3.  SEC USE ONLY

 

 

 

4.  CITIZENSHIP OF PLACE OF ORGANIZATION

 

  Delaware

 

(For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

 

5.  SOLE VOTING POWER

 

  11,964,100

 

6.  SHARED VOTING POWER

 

     

 

7.  SOLE DISPOSITIVE POWER

 

0

 

8.  SHARED DISPOSITIVE POWER

 

0

 

9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  11,964,100

 

10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

  N/A

 

11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

  5.05%

 

12.  TYPE OF REPORTING PERSON

 

  IV

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

Under the Securities Act of 1934

 

Check the following [line] if a fee is being paid with this statement   N/A

 

Item 1(a) - Name of Issuer:

 

  Biogen Idec Inc

 

 

Item 1(b) - Address of Issuer's Principal Executive Offices:

 

  133 BOSTON POST ROAD

  WESTON, MASSACHUSETTS 02493

 

Item 2(a) - Name of Person Filing:

 

  VANGUARD CHESTER FUNDS - VANGUARD PRIMECAP FUND - 23-2311358

 

Item 2(b) – Address of Principal Business Office or, if none, residence:

 

  100 Vanguard Blvd.

  Malvern, PA  19355

 

Item 2(c) – Citizenship:

 

  Delaware

 

Item 2(d) - Title of Class of Securities:

 

  Common Stock

 

Item 2(e) - CUSIP Number

 

  09062X103

 

Item 3 - Type of Filing:

 

  This statement is being filed pursuant to Rule 13d-1.  Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

 

Item 4 - Ownership:

 

  (a) Amount Beneficially Owned:

 

  11,964,100

 

  (b) Percent of Class:

 

  5.05%

 

 

 

  (c)  Number of shares as to which such person has:

 

  (i)  sole power to vote or direct to vote:  11,964,100

 

  (ii)  shared power to vote or direct to vote:     

 

  (iii)  sole power to dispose of or to direct the disposition of:  VANGUARD CHESTER FUNDS - VANGUARD PRIMECAP FUND - 23-2311358

 

  (iv)  shared power to dispose or to direct the disposition of:  VANGUARD CHESTER FUNDS - VANGUARD PRIMECAP FUND - 23-2311358

 

Comments:

 

 

Item 5 - Ownership of Five Percent or Less of a Class:

 

  Not Applicable

 

Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

 

  Not applicable

 

Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company: 

 

  Not Applicable

 

Item 8 - Identification and Classification of Members of Group:

 

  Not applicable

 

Item 9 - Notice of Dissolution of Group:

 

  Not applicable

 

Item 10 - Certification:

 

  By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect.

 

Signature

 

  After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

Date:  01/25/2013

 

By /s/ F. William McNabb III*  

 

F. William McNabb III

 

President and Chief Executive Officer

 

*By: /s/ Glenn Booraem

Glenn Booraem, pursuant to a Power of Attorney filed January 29, 2010, see File Number 005-81485, Incorporated by Reference